CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 200 target
Drug / intervention
Persistent AF ablation assisted with the STAR Apollo Mapping Systemother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05826665
NCT05826665N/ARecruitingUpdate OverdueUpdated 20mo ago · Completion was 11mo ago
Enrollment Stalled
Update Overdue

Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System

Kansas City Heart Rhythm Research Foundation·observational·Posted Apr 24, 2023·Updated Oct 16, 2024

In Brief

An observational study evaluating Persistent AF ablation assisted with the STAR Apollo Mapping System for Persistent Atrial Fibrillation. Currently recruiting, targeting 200 participants across 4 sites.

Signals

Enrollment appears stalled

Detailed Summary

STAR Apollo Mapping System is an FDA cleared mapping technology that can analyze the signals collected during the ablation procedure on the 3D mapping system and give the physician further insight into the AF activation patterns which may assist them in identifying areas responsible for maintaining Atrial Fibrillation (AF). The STAR Apollo Mapping System system allows clinicians, after treating the Pulmonary Veins (PV), to collect data from the atria during clinical AF procedures using standard FDA cleared catheters and devices. This study aims to examine the impact of the STAR Apollo Mapping System on procedural and acute outcomes in a multicenter observational study.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ARecruitingOverdue
202420252026
First PostedApr 24, 2023
Enrollment StartOct 2, 2023
Primary CompletionJul 31, 2025
TodayJul 1, 2026
Enrollment to primary: 1.8 yearsPosted 3.2 years ago

Interventions

Persistent AF ablation assisted with the STAR Apollo Mapping Systemother

This exploratory hypothesis generating data set will be collected during standard AF ablation procedures using FDA cleared technologies as described in their Instructions for Use (IFU). No randomization or experimental protocols will be used during this study, and all follow up will be performed as per the center's standard of care(SOC).